Eli Lilly Lymphoma Drug, Enzastaurin, Fails In Late-Stage Trial
The drug, enzastaurin, was being tested in lymphoma patients who were at high risk of relapse following chemotherapy treatment
eli lilly lymphoma drug enzastaurin fail late stage trial drug enzastaurin test lymphoma patient high risk relapse follow chemotherapy treatment